range
Novartis CEO plays down prospects for Actelion bid: Blick
December 4, 2016 by elegant · Leave a Comment
Novartis Chief Executive Joe Jimenez has played down suggestions the Swiss drugmaker could bid for Swiss biotech group Actelion, which is in talks with U.S. healthcare group Johnson & Johnson about a transaction. Asked by Swiss Sunday newspaper SonntagsBlick
The rest is here:
Novartis CEO plays down prospects for Actelion bid: Blick